Physician profile
Scott I Morrison
NPI 1720083231
$2,627.86
in general payments reported to CMS, 2019-2025
13 companies · $683 in 2025
The $683 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $108 · 2021: $185 · 2022: $322 · 2023: $407 · 2024: $668 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,278.32 | 2019-2025 | Total30, Precision7, Precision 7 |
| Bausch & Lomb Americas INC. | $427.14 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Tarsus Pharmaceuticals, INC. | $212.09 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $146.38 | 2025 | |
| Coopervision INC. | $111.73 | 2022-2024 | Myday Contact Lens |
| Allergan, INC. | $100.81 | 2020-2021 | |
| Sight Sciences, INC. | $80.97 | 2019 | |
| Visioneering Technologies, INC. | $76.90 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.23 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $48.58 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $31.97 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $30.89 | 2025 | |
| Kala Pharmaceuticals, INC. | $18.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.